Sign up to save your podcasts
Or
Share Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing
Matt Galsky describes his Phase 2 study and gives a vision of the future.
View all episodes
By The Uromigos
4.9
5757 ratings
Matt Galsky describes his Phase 2 study and gives a vision of the future.
More shows like The Uromigos
View all
TED Radio Hour
22,048 Listeners
Freakonomics Radio
32,328 Listeners
Planet Money
30,868 Listeners
JAMA Clinical Reviews
500 Listeners
Behind The Knife: The Surgery Podcast
1,308 Listeners
Prostate Cancer Update
13 Listeners
ASCO Daily News
59 Listeners
The Diary Of A CEO with Steven Bartlett
8,864 Listeners
OncLive® On Air
22 Listeners
GU Cast | Urology Podcast
2 Listeners
Oncology Today with Dr Neil Love
57 Listeners
People I (Mostly) Admire
2,070 Listeners
ZOE Science & Nutrition
2,171 Listeners
Two Onc Docs
195 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
45 Listeners